Alpharetta, GA, United States of America

Robert Newton Brey, Iii


Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2000-2006

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Robert Newton Brey, III

Introduction

Robert Newton Brey, III is an accomplished inventor based in Alpharetta, GA (US). He has made significant contributions to the field of gene therapy through his innovative work. With a total of five patents to his name, Brey has established himself as a key figure in the development of novel compositions and methods.

Latest Patents

Brey's latest patents include groundbreaking inventions related to adjuvants and copolymer compositions. One of his notable inventions comprises novel polyoxyethylene/polyoxypropylene block copolymer compositions and compounds. These compositions are particularly useful in gene therapy methods, showcasing the potential for advancements in medical treatments. Another patent focuses on high molecular weight block copolymers, further emphasizing their utility in gene therapy applications.

Career Highlights

Brey is currently associated with Cytrx Corporation, where he continues to push the boundaries of innovation. His work at the company has allowed him to explore new avenues in the field of biotechnology. His dedication to research and development has led to significant advancements in therapeutic methods.

Collaborations

Brey has collaborated with notable colleagues, including Mannarsamy Balasubramanian and Mark Joseph Newman. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Robert Newton Brey, III is a prominent inventor whose work in gene therapy has the potential to transform medical treatments. His innovative patents and collaborations highlight his commitment to advancing biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…